GENTA INCORPORATED /DE/
8-K/A, 1997-09-05
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: GENTA INCORPORATED /DE/, 10-Q/A, 1997-09-05
Next: FIDELITY UNION STREET TRUST II, DEFA14A, 1997-09-05



                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549
   
                                    FORM 8-K/A
    
   
                                Amendment No. 1
    
                                 CURRENT REPORT




     PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934



Date of Report (Date of earliest event reported): June 30, 1997




                               GENTA INCORPORATED
             (Exact name of registrant as specified in its charter)


                         Commission file number 0-19635


            DELAWARE                                     33-0326866
 (State or other jurisdiction of            (IRS Employer Identification Number)
 incorporation or organization)



                 3550 GENERAL ATOMICS COURT, SAN DIEGO, CA 92121
                    (Address of principal executive offices)
                                   (Zip Code)



                                 (619) 455-2700
              (Registrant's telephone number, including area code)






<PAGE>


                               GENTA INCORPORATED

   
                                    FORM 8-K/A
    

                                 CURRENT REPORT

                                TABLE OF CONTENTS


Item 5.  Other Events

Signature


                                      - 2 -


<PAGE>

ITEM 5.  OTHER EVENTS

         On February 6, 1997, the Company announced that,  effective February 7,
1997, the Company's Common Stock, formerly listed on The Nasdaq National Market,
would be listed on The  Nasdaq  SmallCap  Market via an  exception  from the bid
price and capital and surplus  requirements of The Nasdaq SmallCap  Market.  The
Nasdaq  Listing  Qualifications  Panel  (the  "Panel")  granted  the  Company  a
temporary  exception  (the  "Exception")  from  these  standards  subject to the
Company's meeting certain conditions.

         On April  11,  1997,  the  Company  was  notified  that the  Panel  had
determined  to modify  the  terms of the  Exception  as  follows  (the  "Revised
Exception").  First, on or before April 15, 1997, the Company must make a public
filing  with the  Securities  and  Exchange  Commission  (the  "SEC") and Nasdaq
evidencing minimum capital and surplus of $2,700,000.  The filing must contain a
February 28, 1997 balance sheet with pro forma  adjustments  for any significant
transactions occurring on or before the filing date. Second, on or before May 7,
1997,  the Company  must  provide  Nasdaq with an April 30, 1997  balance  sheet
evidencing  compliance with the $1,000,000  maintenance  requirement for capital
and surplus.  Third,  on or before June 9, 1997, the Company must provide Nasdaq
with a May 31, 1997 balance  sheet  evidencing  compliance  with the  $1,000,000
maintenance  requirement for capital and surplus.  Finally, on or before July 7,
1997,  the Company must make a public filing with the SEC and Nasdaq (the "Final
Filing  Requirement")  containing a June 30, 1997  balance  sheet with pro forma
adjustments for any significant  transactions  occurring on or before the filing
date and  evidencing  a  minimum  of  $6,000,000  in  capital  and  surplus  and
compliance with all  requirements for continued  listing.  The Panel has further
informed  the  Company  that in the event the  Company  fails to meet any of the
terms of this Revised Exception, its securities will be immediately deleted from
The Nasdaq Stock Market.

         On April 15,  1997,  in  accordance  with the  Revised  Exception,  the
Company made a public  filing with the SEC and Nasdaq of an unaudited  condensed
consolidated  balance sheet as of February 28, 1997, showing capital and surplus
of $2,722,091.  On May 6, 1997, in accordance  with the Revised  Exception,  the
Company provided Nasdaq with an unaudited condensed  consolidated balance sheet,
showing  capital and surplus of $1,383,984.  On June 6, 1997, in accordance with
the Revised Exception,  the Company provided Nasdaq with an unaudited  condensed
consolidated balance sheet, showing capital and surplus of $1,176,914. To comply
with the Final  Filing  Requirement,  the Company is hereby  filing with the SEC
this current report on Form 8-K containing an unaudited  condensed  consolidated
balance sheet as at June 30, 1997,  showing  capital and surplus of  $13,338,724
and also concurrently sending a copy hereof to Nasdaq.


                                      - 3 -


<PAGE>

                                    SIGNATURE


         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                              GENTA INCORPORATED



Date:  September 5, 1997

                                              /s/Michael S. Weiss
                                              -----------------------------
                                              Michael S. Weiss
                                              Interim Chairman of the Board


                                      - 4 -

<PAGE>

                               GENTA INCORPORATED
                      CONDENSED CONSOLIDATED BALANCE SHEET
                                   (UNAUDITED)

   
<TABLE>
<CAPTION>

                                                                                                          JUNE 30,
                                            ASSETS                                                         1997
                                                                                                   ---------------------

Current assets:
<S>                                                                                                  <C>
   Cash and cash equivalents .....................................................................   $   9,969,724
   Subscription receivable .......................................................................       4,154,007
   Trade accounts receivable .....................................................................         520,630
   Inventories ...................................................................................         873,457
   Other current assets ..........................................................................         190,590
                                                                                                     -------------
Total current assets .............................................................................      15,708,408
                                                                                                     -------------
Property and equipment, net ......................................................................       2,917,910
Intangibles, net .................................................................................       4,074,665
Other assets, net ................................................................................       1,087,149
                                                                                                     -------------
                                                                                                     $  23,788,132
                                                                                                     =============

                          LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
   Accounts payable ..............................................................................   $   2,614,878
   Other accrued expenses ........................................................................       2,210,374
   Deferred revenue ..............................................................................         132,110
   Short term notes payable ......................................................................       2,350,000
   Current portion of notes payable and capital lease obligations ................................         221,602
                                                                                                     -------------
Total current liabilities ........................................................................       7,528,964
                                                                                                     -------------
Notes payable, less current portion ..............................................................         917,431
Deficit in joint venture .........................................................................       2,003,013
Stockholders' equity:
   Preferred stock; 5,000,000 shares authorized:
      Series A convertible preferred stock, $.001 par value; 528,100 shares issued and outstanding
        at June 30, 1997, liquidation value is $29,045,500 at June 30, 1997 ......................             528
      Series C convertible preferred stock, $.001 par value; 1,144 shares issued and outstanding
        at June 30, 1997, liquidation value is $1,202,422 at June 30, 1997 .......................               1
      Series D convertible preferred stock, $.001 par value; 174,580 shares issued and outstanding
        at June 30, 1997, liquidation value is $24,441,200 at June 30, 1997 ......................             175
   Common stock, $.001 par value; 70,000,000 shares authorized; 4,378,852 shares issued and
      outstanding at June 30, 1997 ...............................................................           4,379
   Additional paid-in capital ....................................................................     122,732,087
   Accumulated deficit ...........................................................................    (114,156,246)
   Accrued dividends payable .....................................................................       4,807,776
   Notes receivable from stockholders ............................................................         (49,976)
                                                                                                     -------------
Total stockholders' equity .......................................................................      13,338,724
                                                                                                     -------------
                                                                                                     $  23,788,132
                                                                                                     =============
</TABLE>
    


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission